Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$66.63 USD

66.63
12,908,298

-0.22 (-0.33%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $66.63 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (233 out of 250)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

Benjamin Rains headshot

3 REITs for Dividend Investors to Buy with Stock Market at New Highs

Here are three highly-ranked REITs we found using our Zacks Stock Screener that dividend investors might want to buy with stock indexes at new highs...

Here's Why You Should Hold on to CVS Health (CVS) For Now

Investors can still hold on to CVS Health (CVS) stock, thanks to its solid prospects.

Urmimala Biswas headshot

Walgreens Boots Rallies on KKR's Bid but Market View Mixed

Albeit the market sentiment is bullish on Walgreens Boots' (WBA) potential acquisition deal, many analysts are in doubt about the company's effective approach to get privatized.

CVS Health's New Plans With Aetna May Improve Health Outcomes

CVS Health's (CVS) Health Care Benefits segment develops Medicare program with Aetna.

Want To Retire Early? Learn the Intelligent Investing Secret - November 13, 2019

Accomplishing the financial cushion to retire early is a fantasy for most, but bringing that fantasy to reality is not as difficult as it sounds. If you are willing to make some serious lifestyle adjustments, it can be achievable.

CVS Health's Aetna Prospects Solid, Omnicare Sluggish

CVS Health's (CVS) strong Pharmacy Services segment sales gain traction from growth in specialty services.

The Zacks Analyst Blog Highlights: Mastercard, UnitedHealth, Merck, Qualcomm and CVS Health

The Zacks Analyst Blog Highlights: Mastercard, UnitedHealth, Merck, Qualcomm and CVS Health

Mark Vickery headshot

Top Analyst Reports for Mastercard, UnitedHealth & Merck

Today's Research Daily features new research reports on 16 major stocks, including Mastercard (MA), UnitedHealth Group (UNH) and Merck (MRK).

Stock Market News for Nov 7, 2019

Wall Street moved negligibly on Nov 6 as stocks struggled to sustain the rally earlier in the week.

The Extreme Risks of Trading Your Own Retirement Assets - November 07, 2019

From understanding your risk tolerance to maintaining emotional control, achieving your retirement goals takes a much different investing approach than regular stock trading.

CVS Health (CVS) Beats on Q3 Earnings, Raises '19 EPS Guidance

CVS Health's (CVS) strong year-over-year growth in the top line is aided by a robust performance at the Pharmacy Services segment.

Economic Data Deluge

Economic Data Deluge

Mark Vickery headshot

Q3 Productivity Slips to -0.3%, Labor Costs Rise 3.6%

To see a negative headline read on U.S. Productivity is thankfully quite rare. The last time we saw this was nearly 4 full years ago.

CVS Health (CVS) Q3 Earnings and Revenues Top Estimates

CVS Health (CVS) delivered earnings and revenue surprises of 3.95% and 2.83%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Benjamin Rains headshot

New Highs, Uber Stock & Buy Boston Beer on Hard Seltzer Growth - Free Lunch

U.S. stock indexes hit new highs amid U.S.-China trade war progress. Quarterly earnings results, including Uber. The episode then closes with a look at why The Boston Beer Company (SAM) is a Zacks Rank #1 (Strong Buy) stock...

Dropbox (DBX) to Report Q3 Earnings: What's in the Offing?

Dropbox (DBX) continuous efforts to strengthen cloud-based and AI technologies are likely to have driven the top line in the third quarter.

Easy Investing Secrets to an Early Retirement - November 05, 2019

Achieving the financial freedom to retire early is a dream for most, but making that dream a reality isn't as tricky as it sounds. If you are willing to make some serious lifestyle changes and sacrifices, it can be possible.

Can Pharmacy Services Drive CVS Health's (CVS) Q3 Earnings?

CVS Health's (CVS) Caremark legacy business is expected to have delivered a solid third quarter, backed by the company's robust execution of its formulary and cost-containment tools.

Insight (NSIT) to Report Q3 Earnings: What's in the Offing?

Insight's (NSIT) third-quarter results are likely to have been driven by its balanced portfolio of customer end-markets, and broad product and solutions pipeline.

ANSYS (ANSS) Gears Up for Q3 Earnings: What's in Store?

ANSYS' (ANSS) robust demand for simulation software solutions, particularly from automotive end-market, is likely to drive the third-quarter top line.

Can All-Line Growth Boost CVS Health's (CVS) Q3 Earnings?

The newly-incorporated Health Care Benefits business already registers top-line contributions for CVS Health (CVS).

Sumit Singh headshot

4 Retail Stocks Likely to Outshine This Earnings Season

Retailers are making prudent investments to strengthen digital ecosystem and delivery capabilities. While these drive sales, they entail high costs. Margins remain a key area to watch this reporting cycle.

CVS Health (CVS) Reports Next Week: Wall Street Expects Earnings Growth

CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Extreme Risks of Trading Your Own Retirement Assets - October 30, 2019

From understanding your risk tolerance to maintaining emotional control, achieving your retirement goals takes a much different investing approach than regular stock trading.

CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know

CVS Health (CVS) closed at $65.88 in the latest trading session, marking a +1.2% move from the prior day.